Michael Kelly

Michael Kelly currently works at ARS Pharmaceuticals Operations, Inc., as Director from 2019 and ARS Pharmaceuticals, Inc., as Independent Director from 2019.
Mr. Kelly also formerly worked at NervGen Pharma Corp., as President, Chief Executive Officer & Director from 2023 to 2025, Azur Pharma Ltd., as Member, Jazz Pharmaceuticals Commercial Corp., as Senior Vice President & General Manager from 2011 to 2012, Jazz Pharmaceuticals Plc, as Senior Vice President-Sales & Marketing, Covis Pharmaceuticals, Inc., as President from 2013 to 2016, Emergent Devices, Inc., as President-US Operations from 2016 to 2019, Viropharma, Inc., as Vice President-Sales and Marketing, and Guilford Pharmaceuticals, Inc., as Vice President-Commercial Operations from 2002 to 2005.
Mr. Kelly received his undergraduate degree from The College of New Jersey and Masters Business Admin degree from Rider University.